Genetic Variants of Arachidonate 5-Lipoxygenase–Activating Protein, and Risk of Incident Myocardial Infarction and Ischemic Stroke: A Nested Case-Control Approach
暂无分享,去创建一个
[1] A. Singleton,et al. Phosphodiesterase 4D and 5‐lipoxygenase activating protein in ischemic stroke , 2005, Annals of neurology.
[2] T. Meitinger,et al. ALOX5AP Gene and the PDE4D Gene in a Central European Population of Stroke Patients , 2005, Stroke.
[3] U. Thorsteinsdóttir,et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. , 2005, American journal of human genetics.
[4] J. Gulcher,et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.
[5] Peter Donnelly,et al. A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.
[6] T. Cohnert,et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] P. Donnelly,et al. A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.
[8] M J Malloy,et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. , 1999, Genome research.
[9] N. Risch,et al. A comparison of linkage disequilibrium measures for fine-scale mapping. , 1995, Genomics.
[10] B. Samuelsson. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.
[11] Vilmundur Gudnason,et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction , 2006, Nature Genetics.
[12] S E Hodge,et al. Logistic regression model for analyzing extended haplotype data , 1998, Genetic epidemiology.